Logo image of BLN.CA

BLACKLINE SAFETY CORP (BLN.CA) Stock Fundamental Analysis

TSX:BLN - Toronto Stock Exchange - CA0923821007 - Common Stock - Currency: CAD

6.59  +0.14 (+2.17%)

Fundamental Rating

4

BLN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 13 industry peers in the Electronic Equipment, Instruments & Components industry. BLN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BLN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BLN has reported negative net income.
In the past year BLN has reported a negative cash flow from operations.
In the past 5 years BLN always reported negative net income.
In the past 5 years BLN reported 4 times negative operating cash flow.
BLN.CA Yearly Net Income VS EBIT VS OCF VS FCFBLN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

BLN's Return On Assets of -4.50% is fine compared to the rest of the industry. BLN outperforms 61.54% of its industry peers.
With a decent Return On Equity value of -9.40%, BLN is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
ROA -4.5%
ROE -9.4%
ROIC N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
BLN.CA Yearly ROA, ROE, ROICBLN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 59.21%, BLN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BLN has grown nicely.
BLN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
BLN.CA Yearly Profit, Operating, Gross MarginsBLN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

BLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BLN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLN has been increased compared to 5 years ago.
Compared to 1 year ago, BLN has an improved debt to assets ratio.
BLN.CA Yearly Shares OutstandingBLN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BLN.CA Yearly Total Debt VS Total AssetsBLN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

BLN has an Altman-Z score of 3.30. This indicates that BLN is financially healthy and has little risk of bankruptcy at the moment.
BLN has a Altman-Z score (3.30) which is in line with its industry peers.
A Debt/Equity ratio of 0.14 indicates that BLN is not too dependend on debt financing.
BLN has a better Debt to Equity ratio (0.14) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 3.3
ROIC/WACCN/A
WACC7.51%
BLN.CA Yearly LT Debt VS Equity VS FCFBLN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

BLN has a Current Ratio of 2.25. This indicates that BLN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BLN (2.25) is better than 61.54% of its industry peers.
A Quick Ratio of 1.97 indicates that BLN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.97, BLN is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.97
BLN.CA Yearly Current Assets VS Current LiabilitesBLN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.75% over the past year.
Looking at the last year, BLN shows a very strong growth in Revenue. The Revenue has grown by 31.68%.
The Revenue has been growing by 30.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)68.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
Revenue 1Y (TTM)31.68%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%43.11%

3.2 Future

BLN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.75% yearly.
Based on estimates for the next years, BLN will show a very strong growth in Revenue. The Revenue will grow by 22.44% on average per year.
EPS Next Y61.38%
EPS Next 2Y51.23%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue Next Year23.82%
Revenue Next 2Y23.01%
Revenue Next 3Y29.63%
Revenue Next 5Y22.44%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BLN.CA Yearly Revenue VS EstimatesBLN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
BLN.CA Yearly EPS VS EstimatesBLN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 135.00, which means the current valuation is very expensive for BLN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLN indicates a somewhat cheap valuation: BLN is cheaper than 76.92% of the companies listed in the same industry.
BLN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.49.
Industry RankSector Rank
PE N/A
Fwd PE 135
BLN.CA Price Earnings VS Forward Price EarningsBLN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLN.CA Per share dataBLN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as BLN's earnings are expected to grow with 20.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.23%
EPS Next 3Y20.71%

More info and screens

0

5. Dividend

5.1 Amount

BLN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKLINE SAFETY CORP

TSX:BLN (5/1/2025, 7:00:00 PM)

6.59

+0.14 (+2.17%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-12 2025-03-12/bmo
Earnings (Next)06-11 2025-06-11
Inst Owners25.12%
Inst Owner ChangeN/A
Ins Owners3.33%
Ins Owner ChangeN/A
Market Cap570.69M
Analysts80
Price Target9.03 (37.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)86.25%
Min EPS beat(2)72.5%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)40.75%
Min EPS beat(4)-32.01%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)10.82%
EPS beat(12)5
Avg EPS beat(12)5.67%
EPS beat(16)5
Avg EPS beat(16)-12.26%
Revenue beat(2)1
Avg Revenue beat(2)3.79%
Min Revenue beat(2)-6.38%
Max Revenue beat(2)13.97%
Revenue beat(4)3
Avg Revenue beat(4)4.18%
Min Revenue beat(4)-6.38%
Max Revenue beat(4)13.97%
Revenue beat(8)4
Avg Revenue beat(8)1.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.07%
Revenue beat(16)6
Avg Revenue beat(16)-0.64%
PT rev (1m)1.64%
PT rev (3m)20.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-500%
EPS NY rev (1m)0%
EPS NY rev (3m)-456.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.8%
Revenue NY rev (1m)1.35%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 135
P/S 4.12
P/FCF N/A
P/OCF N/A
P/B 6.76
P/tB 7.31
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0.05
Fwd EY0.74%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS1.6
BVpS0.97
TBVpS0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.5%
ROE -9.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.21%
FCFM N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 107.14%
Cap/Sales 6.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.97
Altman-Z 3.3
F-Score5
WACC7.51%
ROIC/WACCN/A
Cap/Depr(3y)111.77%
Cap/Depr(5y)105.56%
Cap/Sales(3y)8.6%
Cap/Sales(5y)9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
EPS Next Y61.38%
EPS Next 2Y51.23%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue 1Y (TTM)31.68%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%43.11%
Revenue Next Year23.82%
Revenue Next 2Y23.01%
Revenue Next 3Y29.63%
Revenue Next 5Y22.44%
EBIT growth 1Y62.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.88%
EBIT Next 3Y65.48%
EBIT Next 5Y39.66%
FCF growth 1Y82.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y97.58%
OCF growth 3YN/A
OCF growth 5YN/A